|
|
|
|
S. Brenner on C. elegans
Over at Flies & Bikes, GrumpyBob has a post on a perspectives piece from Sydney Brenner in the latest issue of Genetics.'This brief article ... presents an account of the origins of Caenorhabditis elegans research, by the beast...
|
|
|
Proximity to Biocluster, Grants Persuades Carbon Nanopores to Open its HQ in Philly Suburb
_ Proximity to Biocluster, Grants Persuades Carbon Nanopores to Open its HQ in Philly Suburb.
|
|
|
Laser Trapping Tech Advances Single-Cell Genomics in Quake's Stanford Lab
/ Genome Technology May 29, 2009 / Genome Technology May 1, 2009 / Genome Technology March 27, 2009 / Genome Technology BioArray News BioInform BioArray News Young Investigator Profile David Mathews University of Rochester Assistant...
|
|
|
Symbolic Scatter Plot Helps Visualize Patterns Within DNA Sequence
/ Genome Technology May 29, 2009 / Genome Technology May 1, 2009 / Genome Technology March 27, 2009 / Genome Technology BioArray News BioInform BioArray News Young Investigator Profile David Mathews University of Rochester Assistant...
|
|
|
New Mouse Model Aims to Unlock Neurological Disorders
/ Genome Technology June 30, 2009 / Genome Technology June 15, 2009 / GenomeWeb Daily News May 31, 2009 / Genome Technology BioArray News BioInform BioArray News Young Investigator Profile David Mathews University of Rochester Assistant...
|
|
|
Study Questions CA-125 for Ovarian Cancer Relapse
/ Genome Technology May 29, 2009 / Genome Technology May 29, 2009 / Genome Technology May 29, 2009 / Genome Technology BioArray News BioInform BioArray News Young Investigator Profile David Mathews University of Rochester Assistant Professor...
|
|
|
Genomic Medicine Kicks Off
As genetic and genomic tests move into routine clinical application, hospitals have to change the way they diagnose and treat disease.Education, both for patients and for physicians, will be key to setting the standard of care. Full...
|
|
|
Like a Love Triangle
Roche is leaving PhRMA for BIO.Genentech, which Roche recently acquired, was a member of BIO and during the reorganization of the companies, Roche assets in the US became Genentech. 'Genentech and Roche believe BIO's purpose is closely...
|
|
|
Cancer Run-Down
The University of Rochester's David Mathews is building algorithms to predict secondary structures of RNA and applying that knowledge to finding novel, noncoding RNA in the genome and uncovering what those RNAs do.In addition, he says...
|
|
|
ChIP Goes Genome-Scale
Studies of chromatin immunoprecipitation were once slow, tedious affairs.But thanks to microarrays and next-gen sequencers, scientists are beginning to run their ChIP queries across entire genomes. Full-text access for registered users...
|
